Literature DB >> 20919417

Cefuroxime concentrations in serum, urine and bile: pharmacokinetic profile.

J M Brogard, J Kopferschmitt, M Pinget, J P Arnaud, J Lavillaureix.   

Abstract

Entities:  

Year:  1977        PMID: 20919417      PMCID: PMC1543255     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  4 in total

1.  Cefuroxime: pharmacokinetics after a short infusion, and in vitro activity against hospital pathogens.

Authors:  C S Goodwin; C H Dash; J P Hill; A D Goldberg
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

2.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Cefuroxime - a new cephalosporin antibiotic.

Authors:  C H O'Callaghan; R B Sykes; D M Ryan; R D Foord; P W Muggleton
Journal:  J Antibiot (Tokyo)       Date:  1976-01       Impact factor: 2.649

4.  Cefuroxime, a new cephalosporin antibiotic: activity in vivo.

Authors:  D M Ryan; C O'Callaghan; P W Muggleton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

  4 in total
  3 in total

1.  High pressure liquid chromatographic analysis of the serum concentration of cefuroxime after an intravenous bolus injection of cefuroxime in patients with a coronary artery bypass grafting.

Authors:  M J Koot; F N IJdenberg; R M Stuurman; J Poell; L J Bras; J J Langemeijer; L Lie-A-Huen
Journal:  Pharm Weekbl Sci       Date:  1992-12-11

Review 2.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

3.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.